| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 35 |
| 1 | METHYLPREDNISOLONE | 26 |
| 2 | RITUXIMAB | 25 |
| 3 | TACROLIMUS | 25 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 25 |
| 5 | TACROLIMUS OINTMENT 0.1% | 25 |
| 6 | METHOTREXATE | 15 |
| 7 | METHOTREXATE SODIUM | 15 |
| 8 | PREDNISONE | 11 |
| 9 | IBRUTINIB | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MESNA INJECTION | 7 | 0.0008 |
| 1 | MESNA | 7 | 0.0008 |
| 2 | VELAGLUCERASE ALFA | 1 | 0.0005 |
| 3 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 3 | 0.0004 |
| 4 | MYCOPHENOLATE MOFETIL | 35 | 0.0003 |
| 5 | TACROLIMUS OINTMENT 0.1% | 25 | 0.0002 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 25 | 0.0002 |
| 7 | METHYLPREDNISOLONE | 26 | 0.0002 |
| 8 | FILGRASTIM | 7 | 0.0002 |
| 9 | TACROLIMUS | 25 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 1 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 2 | Topoisomerase Inhibitor [EPC] | 7 | 0.0001 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 25 | 0.0001 |
| 4 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 5 | BCL-2 Inhibitor [EPC] | 4 | 0.0001 |
| 6 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Complement Inhibitor [EPC] | 3 | 0.0001 |
| 8 | Leukocyte Growth Factor [EPC] | 7 | 0.0000 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |